13F Holdings
中文EN

ECOR electroCore, Inc.

Electromedical & Electrotherapeutic Apparatus · Nasdaq · SEC CIK 1560258 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (2025Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY27.2%
TTM net income YoY-17.5%
TTM EPS YoY-3.8%
Revenue 3-yr CAGR55.1%
Net income 3-yr CAGR—

Margins

Gross margin86.8%
Operating margin-41.1%
Net margin-43.6%
FCF margin-25.8%
EBITDA margin-39.5%

Returns

ROE-478.7%
ROA-71.4%
ROIC (approx.)-1,217.4%
Asset turnover1.64x

Leverage & solvency

Liabilities / assets109.2%
Debt / equity—
Current ratio1.38x
Interest coverage-882.75x

Cash quality & payout

Operating cash flow / net income0.59x
Accruals ratio-29.5%
Payout ratio—
Capex / revenue0.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$9.69M$9.45M$9.58M$9.24M$8.69M$7.38M$6.72M$7.05M
Cost of revenue$1.12M$1.27M$1.22M$1.07M$1.22M$939,000$1.01M$994,000
Gross profit$8.57M$8.18M$8.36M$8.17M$7.47M$6.44M$5.71M$6.05M
R&D expense————$662,000$511,000$642,000$805,000
SG&A expense$9.70M$10.13M$12.94M$10.19M$9.69M$9.44M$8.89M$8.32M
Operating income-$1.56M-$2.77M-$5.32M-$2.94M-$2.88M-$3.51M-$3.82M-$3.07M
Interest expense$3,700$3,300$4,000$2,100$3,300$4,500$5,000$5,400
Pretax income-$1.47M-$3.06M-$5.59M-$2.98M-$3.40M-$3.67M-$3.90M-$3.20M
Income tax-$126,000$0-$321,000$51,000$0$0-$48,000$29,000
Net income-$1.34M-$3.06M-$5.27M-$3.04M-$3.40M-$3.67M-$3.85M-$3.23M
EBITDA-$1.55M-$2.77M-$5.29M-$2.83M-$2.77M-$3.38M-$3.67M-$2.90M
EPS (basic)-0.13-0.33-0.59—-0.40-0.44-0.47—
EPS (diluted)-0.13-0.33-0.59—-0.40-0.44-0.47—
Weighted avg. shares (diluted)9.95M9,4048,953—8.45M8,3168,289—
Balance sheet
Cash & equivalents$6.31M$8.50M$4.85M$7.04M$7.86M$3.37M$3.78M$3.70M
Short-term investments$1.20M$1.54M$3.98M$4.58M$5.09M$3.77M$3.98M$8.52M
Receivables$1.62M$909,000$872,000$1.03M$1.48M$813,000$1.46M$1.37M
Inventory$3.96M$2.42M$1.98M$1.63M$1.21M$1.43M$1.73M$1.68M
Current assets$14.45M$14.12M$12.53M$15.67M$17.35M$10.56M$11.97M$16.30M
PP&E, net$371,000$375,000$364,000$382,000$194,000$197,000$183,000$158,000
Total assets$17.26M$17.06M$15.48M$18.67M$21.41M$14.56M$16.04M$20.47M
Current liabilities$10.78M$11.67M$12.31M$11.35M$12.14M$9.62M$7.86M$9.15M
Short-term debt$313,000$1.00M$250,000—————
Long-term debt$6.58M$5.77M$6.44M$6.61M$6.53M———
Total debt$6.89M$6.77M$6.69M$6.61M$6.53M———
Total liabilities$19.77M$19.85M$21.17M$20.38M$22.48M$13.45M$11.68M$12.93M
Shareholders' equity-$2.51M-$2.79M-$5.69M-$1.71M-$1.07M$1.11M$4.37M$7.54M
Net debt$589,000-$1.73M$1.83M-$428,000-$1.33M———
Shares outstanding9.17M9.00M8.13M8.00M7.64M7.47M7.42M6.65M
Cash flow statement
Operating cash flow-$2.83M-$3.52M-$3.01M-$1.54M-$1.67M-$623,000-$4.36M-$1.25M
Capital expenditure$0$4,000$2,000$0$4,000$25,000$37,000—
Free cash flow-$2.83M-$3.52M-$3.01M-$1.54M-$1.67M-$648,000-$4.39M—
Investing cash flow$348,000$2.43M$597,000$518,000-$1.33M$185,000$4.50M-$501,000
Financing cash flow$288,000$4.74M$230,000-$40,000$7.48M$3,000$180,000$371,000
Depreciation & amortization$9,000$6,000$21,000$107,000$118,000$121,000$155,000$168,000
Stock-based compensation$617,000$755,000$1.04M$470,000$415,000$505,000$540,000$514,000

Free plan shows the latest 8 periods; Pro shows all 39 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.